Defibrotide Intravenous and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Defibrotide Intravenous and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: defibrotide
Brand name: Defitelio
Synonyms: Defibrotide, Defibrotide Sodium
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Defibrotide Intravenous-Moxifloxacin
- Defibrotide Intravenous-Moxifloxacin (Systemic)
- Defibrotide Intravenous-Moxifloxacin Hydrochloride
- Defibrotide Intravenous-Moxifloxacin Injection
- Defibrotide Intravenous-Moxifloxacin Intravenous
- Defibrotide Intravenous-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Defibrotide Sodium
- Moxetumomab pasudotox-tdfk Intravenous-Definity
- Moxetumomab pasudotox-tdfk Intravenous-Defitelio
- Moxetumomab pasudotox-tdfk Intravenous-Deflazacort
- Moxetumomab pasudotox-tdfk Intravenous-Deflazacort Oral Suspension
- Moxetumomab pasudotox-tdfk Intravenous-Deflazacort Tablets